As reported previously by our group and others [11,12,13,14], GBT1118 treatment resulted in an increase in total Hb, red blood cell (RBC) counts and hematocrit (HCT) percentages in SCD mice, comparable to those in non-SCD mice (Figure 2; Supplementary Data). Here, GSTM1 is linked to Schnyder corneal dystrophy.